Back to ABT
Grantham, Mayo, Van Otterloo & Co. LLC → ABT
Grantham, Mayo, Van Otterloo & Co. LLC ABT Position History
Abbott Laboratories • Healthcare
Quarters held
14
Latest value
$798M
Q2 2026
Peak value
$1.1B
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $166.9M |
| Q2 2023 | $312.2M |
| Q3 2023 | $354.9M |
| Q4 2023 | $481.6M |
| Q1 2024 | $614.7M |
| Q2 2024 | $601.9M |
| Q3 2024 | $810.6M |
| Q4 2024 | $893.2M |
| Q1 2025 | $1.1B |
| Q2 2025 | $1.1B |
| Q3 2025 | $1.1B |
| Q4 2025 | $1.1B |
| Q1 2026 | $914.9M |
| Q2 2026 | $798M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $798M | 8.79M | — | — |
| Q1 2026 | $914.9M | 8.91M | — | — |
| Q4 2025 | $1.1B | 8.48M | — | — |
| Q3 2025 | $1.1B | 8.18M | — | — |
| Q2 2025 | $1.1B | 7.81M | — | — |
| Q1 2025 | $1.1B | 8.11M | — | — |
| Q4 2024 | $893.2M | 7.90M | — | — |
| Q3 2024 | $810.6M | 7.11M | — | — |
| Q2 2024 | $601.9M | 5.79M | — | — |
| Q1 2024 | $614.7M | 5.41M | — | — |
| Q4 2023 | $481.6M | 4.38M | — | — |
| Q3 2023 | $354.9M | 3.66M | — | — |
| Q2 2023 | $312.2M | 2.86M | — | — |
| Q1 2023 | $166.9M | 1.65M | — | — |
Other funds holding ABT
$22.4B
$21.5B
$19.8B
$10.7B
$10.5B
$10.3B